GLP1-S

• Raw ingredients manufactured by a federally regulated & audited labratory
• Packaged in a GMP (Good Manufacturing Practices) facility
• Third party testing conducted by a federally audited, ISO certified analytical lab
• Greater than 99% pure

GLP1 (Ac-Lys26-[γ-Glu-Lys-(C18 diacid)]-GLP-1[7-37]) is a long-acting, acylated analog of human glucagon-like peptide-1 engineered for strong albumin binding and once-weekly pharmacokinetics. Pre-clinical studies and late-stage trials show potent, glucose-dependent insulin secretion, slowed gastric emptying, and marked appetite suppression that translate into durable reductions in HbA1c and body weight. Rodent data further indicate cardioprotective, neuroprotective, and anti-steatotic actions via AMPK activation and reduced oxidative stress, with minimal hypoglycemia risk owing to preserved glucagon counter-regulation.